(1S,19R)-20-[2-[3-acetyl-5-(2-methylpyrimidin-5-yl)indazol-1-yl]acetyl]-6-bromo-19-iodo-11,16-dioxa-3,5,20-triazatricyclo[16.2.1.04,9]henicosa-4(9),5,7-trien-2-one

C32H33BrIN7O5 — CID 174097878

IUPAC(1S,19R)-20-[2-[3-acetyl-5-(2-methylpyrimidin-5-yl)indazol-1-yl]acetyl]-6-bromo-19-iodo-11,16-dioxa-3,5,20-triazatricyclo[16.2.1.04,9]henicosa-4(9),5,7-trien-2-one
SMILESCC(=O)c1nn(CC(=O)N2[C@H](I)C3COCCCCOCc4ccc(Br)nc4NC(=O)[C@@H]2C3)c2ccc(-c3cnc(C)nc3)cc12
InChIInChI=1S/C32H33BrIN7O5/c1-18(42)29-24-11-20(23-13-35-19(2)36-14-23)5-7-25(24)40(39-29)15-28(43)41-26-12-22(30(41)34)17-46-10-4-3-9-45-16-21-6-8-27(33)37-31(21)38-32(26)44/h5-8,11,13-14,22,26,30H,3-4,9-10,12,15-17H2,1-2H3,(H,37,38,44)/t22?,26-,30-/m0/s1
InChIKeySDXWUCALVDTXGV-RWMHTRQUSA-N
MW802.47 g/mol
LogP5.11
Rot. Bonds4

About (1S,19R)-20-[2-[3-acetyl-5-(2-methylpyrimidin-5-yl)indazol-1-yl]acetyl]-6-bromo-19-iodo-11,16-dioxa-3,5,20-triazatricyclo[16.2.1.04,9]henicosa-4(9),5,7-trien-2-one

(1S,19R)-20-[2-[3-acetyl-5-(2-methylpyrimidin-5-yl)indazol-1-yl]acetyl]-6-bromo-19-iodo-11,16-dioxa-3,5,20-triazatricyclo[16.2.1.04,9]henicosa-4(9),5,7-trien-2-one (PubChem CID 174097878) has the molecular formula C32H33BrIN7O5 and a molecular weight of 802.47 g/mol. Its IUPAC name is (1S,19R)-20-[2-[3-acetyl-5-(2-methylpyrimidin-5-yl)indazol-1-yl]acetyl]-6-bromo-19-iodo-11,16-dioxa-3,5,20-triazatricyclo[16.2.1.04,9]henicosa-4(9),5,7-trien-2-one.

Molecular Properties

Compound Name(1S,19R)-20-[2-[3-acetyl-5-(2-methylpyrimidin-5-yl)indazol-1-yl]acetyl]-6-bromo-19-iodo-11,16-dioxa-3,5,20-triazatricyclo[16.2.1.04,9]henicosa-4(9),5,7-trien-2-one
PubChem CID174097878
Molecular FormulaC32H33BrIN7O5
Molecular Weight802.47 g/mol
Exact Mass801.08
IUPAC Name(1S,19R)-20-[2-[3-acetyl-5-(2-methylpyrimidin-5-yl)indazol-1-yl]acetyl]-6-bromo-19-iodo-11,16-dioxa-3,5,20-triazatricyclo[16.2.1.04,9]henicosa-4(9),5,7-trien-2-one
SMILESCC(=O)c1nn(CC(=O)N2[C@H](I)C3COCCCCOCc4ccc(Br)nc4NC(=O)[C@@H]2C3)c2ccc(-c3cnc(C)nc3)cc12
InChIInChI=1S/C32H33BrIN7O5/c1-18(42)29-24-11-20(23-13-35-19(2)36-14-23)5-7-25(24)40(39-29)15-28(43)41-26-12-22(30(41)34)17-46-10-4-3-9-45-16-21-6-8-27(33)37-31(21)38-32(26)44/h5-8,11,13-14,22,26,30H,3-4,9-10,12,15-17H2,1-2H3,(H,37,38,44)/t22?,26-,30-/m0/s1
InChIKeySDXWUCALVDTXGV-RWMHTRQUSA-N
XLogP5.11
TPSA141.43 Ų
H-Bond Donors1
H-Bond Acceptors10
Rotatable Bonds4
Heavy Atoms46
Complexity

Lipinski Rule of Five

2 violations

RuleValue
MW ≤ 500802.47
LogP ≤ 55.11
H-Bond Donors ≤ 51
H-Bond Acceptors ≤ 1010

Computed Properties (RDKit)

Structural Alerts{'alert_name': '2-halo_pyridine', 'substructure': 'N/A'}, {'alert_name': 'alkyl_halide', 'substructure': 'N/A'}, {'alert_name': 'iodine', 'substructure': 'N/A'}, {'alert_name': 'N-C-halo', 'substructure': 'N/A'}

Analyze (1S,19R)-20-[2-[3-acetyl-5-(2-methylpyrimidin-5-yl)indazol-1-yl]acetyl]-6-bromo-19-iodo-11,16-dioxa-3,5,20-triazatricyclo[16.2.1.04,9]henicosa-4(9),5,7-trien-2-one with MolForge

Explore ADMET properties, 3D molecular structure, drug-likeness score, and discover similar compounds using our AI-powered platform.

Launch Full Analysis

Related Compounds

Frequently Asked Questions

What is the IUPAC name of (1S,19R)-20-[2-[3-acetyl-5-(2-methylpyrimidin-5-yl)indazol-1-yl]acetyl]-6-bromo-19-iodo-11,16-dioxa-3,5,20-triazatricyclo[16.2.1.04,9]henicosa-4(9),5,7-trien-2-one?
The IUPAC name of (1S,19R)-20-[2-[3-acetyl-5-(2-methylpyrimidin-5-yl)indazol-1-yl]acetyl]-6-bromo-19-iodo-11,16-dioxa-3,5,20-triazatricyclo[16.2.1.04,9]henicosa-4(9),5,7-trien-2-one (CID 174097878) is (1S,19R)-20-[2-[3-acetyl-5-(2-methylpyrimidin-5-yl)indazol-1-yl]acetyl]-6-bromo-19-iodo-11,16-dioxa-3,5,20-triazatricyclo[16.2.1.04,9]henicosa-4(9),5,7-trien-2-one.
What is the SMILES notation for (1S,19R)-20-[2-[3-acetyl-5-(2-methylpyrimidin-5-yl)indazol-1-yl]acetyl]-6-bromo-19-iodo-11,16-dioxa-3,5,20-triazatricyclo[16.2.1.04,9]henicosa-4(9),5,7-trien-2-one?
The canonical SMILES for (1S,19R)-20-[2-[3-acetyl-5-(2-methylpyrimidin-5-yl)indazol-1-yl]acetyl]-6-bromo-19-iodo-11,16-dioxa-3,5,20-triazatricyclo[16.2.1.04,9]henicosa-4(9),5,7-trien-2-one is CC(=O)c1nn(CC(=O)N2[C@H](I)C3COCCCCOCc4ccc(Br)nc4NC(=O)[C@@H]2C3)c2ccc(-c3cnc(C)nc3)cc12.
What is the InChIKey of (1S,19R)-20-[2-[3-acetyl-5-(2-methylpyrimidin-5-yl)indazol-1-yl]acetyl]-6-bromo-19-iodo-11,16-dioxa-3,5,20-triazatricyclo[16.2.1.04,9]henicosa-4(9),5,7-trien-2-one?
The InChIKey is SDXWUCALVDTXGV-RWMHTRQUSA-N. The full InChI is InChI=1S/C32H33BrIN7O5/c1-18(42)29-24-11-20(23-13-35-19(2)36-14-23)5-7-25(24)40(39-29)15-28(43)41-26-12-22(30(41)34)17-46-10-4-3-9-45-16-21-6-8-27(33)37-31(21)38-32(26)44/h5-8,11,13-14,22,26,30H,3-4,9-10,12,15-17H2,1-2H3,(H,37,38,44)/t22?,26-,30-/m0/s1.
What are the key properties of (1S,19R)-20-[2-[3-acetyl-5-(2-methylpyrimidin-5-yl)indazol-1-yl]acetyl]-6-bromo-19-iodo-11,16-dioxa-3,5,20-triazatricyclo[16.2.1.04,9]henicosa-4(9),5,7-trien-2-one?
(1S,19R)-20-[2-[3-acetyl-5-(2-methylpyrimidin-5-yl)indazol-1-yl]acetyl]-6-bromo-19-iodo-11,16-dioxa-3,5,20-triazatricyclo[16.2.1.04,9]henicosa-4(9),5,7-trien-2-one has a molecular weight of 802.47 g/mol, XLogP of 5.11, 4 rotatable bonds, 1 hydrogen bond donors, and 10 hydrogen bond acceptors.
Where does this data come from?
All data for (1S,19R)-20-[2-[3-acetyl-5-(2-methylpyrimidin-5-yl)indazol-1-yl]acetyl]-6-bromo-19-iodo-11,16-dioxa-3,5,20-triazatricyclo[16.2.1.04,9]henicosa-4(9),5,7-trien-2-one is sourced from PubChem (CID 174097878), the world's largest open chemistry database maintained by the National Library of Medicine (NIH).